Richard S Levy
Director at Madrigal Pharmaceuticals, Inc. (MDGL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $7.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 22SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 4027,657 held (−0%) | $506.68 | $20K | -6.9% |
| May 22SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 32027,337 held (−1%) | $508.24 | $163K | -7.2% |
| May 22SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 15127,186 held (−1%) | $510.36 | $77K | -7.6% |
| May 22SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 61026,576 held (−2%) | $511.40 | $312K | -7.8% |
| May 22SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 43926,137 held (−2%) | $512.50 | $225K | -8.0% |
| May 22SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 4026,097 held (−0%) | $512.97 | $21K | -8.0% |
| May 22SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 34325,754 held (−1%) | $514.67 | $177K | -8.3% |
| May 22SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 65725,097 held (−3%) | $515.92 | $339K | -8.6% |
| May 22SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 72324,374 held (−3%) | $516.87 | $374K | -8.7% |
| May 22SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,49722,877 held (−6%) | $517.59 | $775K | -8.9% |
| May 22SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 78222,095 held (−3%) | $518.76 | $406K | -9.1% |
| May 22SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 8022,015 held (−0%) | $519.98 | $42K | -9.3% |
| Nov 14SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 14629,551 held (−0%) | $514.67 | $75K | -8.3% |
| Nov 14SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 91928,632 held (−3%) | $515.64 | $474K | -8.5% |
| Nov 14SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 64527,987 held (−2%) | $517.51 | $334K | -8.8% |
| Nov 14SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 83527,152 held (−3%) | $518.53 | $433K | -9.0% |
| Nov 14SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,35525,797 held (−5%) | $519.67 | $704K | -9.2% |
| Nov 14SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 30825,489 held (−1%) | $520.68 | $160K | -9.4% |
| Nov 14SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,09424,395 held (−4%) | $521.79 | $571K | -9.6% |
| Nov 14SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,43422,961 held (−6%) | $522.70 | $750K | -9.7% |
| Nov 14SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 81122,150 held (−4%) | $523.66 | $425K | -9.9% |
| Nov 14SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 15321,997 held (−1%) | $524.49 | $80K | -10.1% |
| Nov 14SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 12021,877 held (−1%) | $526.68 | $63K | -10.4% |
| Nov 14SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 20021,677 held (−1%) | $527.85 | $106K | -10.6% |
| Nov 14SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 44021,237 held (−2%) | $528.60 | $233K | -10.8% |
| Nov 14SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 4021,197 held (−0%) | $530.21 | $21K | -11.0% |
- Sell
Director Richard S Levy sold $20K of MDGL at $506.68 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Richard S Levy sold $163K of MDGL at $508.24 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Richard S Levy sold $77K of MDGL at $510.36 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Richard S Levy sold $312K of MDGL at $511.40 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Richard S Levy sold $225K of MDGL at $512.50 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Richard S Levy sold $21K of MDGL at $512.97 — pre-scheduled 10b5-1 plan sale.